GMP Update: Reducing Obstacles to Innovation
FDA offers new policies to encourage modern manufacturing approaches and automated systems, to simplify postapproval changes, and to avoid problems with sterile products.
For full article Click Here
Journal:
Pharmaceutical Technology, Oct 2, 2003.
Copyright:
© Advanstar Communications, Inc. All rights reserved.
